{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T21:20:13Z","timestamp":1784841613345,"version":"3.55.0"},"reference-count":66,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of the Medical Sciences"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1097\/maj.0b013e3181d9bb3b","type":"journal-article","created":{"date-parts":[[2010,5,11]],"date-time":"2010-05-11T02:42:41Z","timestamp":1273545761000},"page":"301-308","source":"Crossref","is-referenced-by-count":49,"title":["Paraneoplastic Neurological Syndromes: Unusual Presentations of Cancer. A Practical Review"],"prefix":"10.1016","volume":"340","author":[{"given":"Tareq","family":"Braik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur T.","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Telfer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"McDunn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1097\/MAJ.0b013e3181d9bb3b_bb0010","first-page":"732","article-title":"Paraneoplastic neurological syndromes: diagnosis and treatment","volume":"20","author":"Graus","year":"2007","journal-title":"Curr Opin Neurol"},{"key":"10.1097\/MAJ.0b013e3181d9bb3b_bb0015","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1136\/jcp.50.12.975","article-title":"Neurological paraneoplastic syndromes","volume":"50","author":"Nath","year":"1997","journal-title":"J Clin Pathol"},{"key":"10.1097\/MAJ.0b013e3181d9bb3b_bb0020","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0733-8619(02)00037-3","article-title":"Paraneoplastic neurologic syndromes","volume":"21","author":"Bataller","year":"2003","journal-title":"Neurol Clin"},{"key":"10.1097\/MAJ.0b013e3181d9bb3b_bb0025","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1750-3639.1999.tb00226.x","article-title":"Paraneoplastic neurologic syndromes: pathogenesis and physiopathology","volume":"9","author":"Dalmau","year":"1999","journal-title":"Brain Pathol"},{"key":"10.1097\/MAJ.0b013e3181d9bb3b_bb0030","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/00005792-199203000-00001","article-title":"Anti-Hu associated paraneoplastic encephalomyelitis\/sensory neuronopathy: a clinical study of 71 patients","volume":"71","author":"Dalmau","year":"1992","journal-title":"Medicine (Baltimore)"},{"key":"10.1097\/MAJ.0b013e3181d9bb3b_bb0035","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1212\/01.WNL.0000129983.06983.4E","article-title":"Antibody-positive paraneoplastic neurologic syndromes: value of CT and PET for tumor diagnosis","volume":"63","author":"Linke","year":"2004","journal-title":"Neurology"},{"key":"10.1097\/MAJ.0b013e3181d9bb3b_bb0040","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S1474-4422(08)70060-7","article-title":"Paraneoplastic syndromes of the CNS","volume":"7","author":"Dalmau","year":"2008","journal-title":"Lancet Neurol"},{"key":"10.1097\/MAJ.0b013e3181d9bb3b_bb0045","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1093\/brain\/124.6.1138","article-title":"Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients","volume":"124","author":"Graus","year":"2001","journal-title":"Brain"},{"key":"10.1097\/MAJ.0b013e3181d9bb3b_bb0050","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1093\/brain\/awh247","article-title":"FDG-PET improves tumour detection in patients with paraneoplastic neurological syndromes","volume":"127","author":"Younes-Mhenni","year":"2004","journal-title":"Brain"},{"key":"10.1097\/MAJ.0b013e3181d9bb3b_bb0055","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1212\/01.wnl.0000252379.81933.80","article-title":"Orchiectomy for suspected microscopic tumor in patients with anti-Ma2-associated encephalitis","volume":"68","author":"Mathew","year":"2007","journal-title":"Neurology"},{"key":"10.1097\/MAJ.0b013e3181d9bb3b_bb0060","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1212\/WNL.44.11.2145","article-title":"Intrathecal synthesis of the anti-Hu antibody in patients with paraneoplastic encephalomyelitis or sensory neuronopathy: clinical-immunologic correlation","volume":"44","author":"Vega","year":"1994","journal-title":"Neurology"},{"key":"10.1097\/MAJ.0b013e3181d9bb3b_bb0065","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1093\/brain\/123.7.1481","article-title":"Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients","volume":"123","author":"Gultekin","year":"2000","journal-title":"Brain"},{"key":"10.1097\/MAJ.0b013e3181d9bb3b_bb0070","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.4065\/78.11.1363","article-title":"Clinical, magnetic resonance imaging, and electroencephalographic findings in paraneoplastic limbic encephalitis","volume":"78","author":"Lawn","year":"2003","journal-title":"Mayo Clin Proc"},{"key":"10.1097\/MAJ.0b013e3181d9bb3b_bb0075","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1136\/jnnp.2003.034447","article-title":"Recommended diagnostic criteria for paraneoplastic neurological syndromes","volume":"75","author":"Graus","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1097\/MAJ.0b013e3181d9bb3b_bb0080","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0002-9629(15)40733-5","article-title":"Autoantibodies in paraneoplastic neurological syndrome","volume":"319","author":"Inuzuka","year":"2000","journal-title":"Am J Med Sci"},{"key":"10.1097\/MAJ.0b013e3181d9bb3b_bb0085","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1212\/01.wnl.0000259612.19249.4d","article-title":"Can antibodies in serum predict the presence of microscopic tumors?","volume":"68","author":"Voltz","year":"2007","journal-title":"Neurology"},{"key":"10.1097\/MAJ.0b013e3181d9bb3b_bb0090","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1212\/WNL.44.12.2241","article-title":"Neurologic paraneoplastic antibodies (anti-Yo; anti-Hu; anti-Ri): the case for a nomenclature based on antibody and antigen specificity","volume":"44","author":"Dalmau","year":"1994","journal-title":"Neurology"},{"key":"10.1097\/MAJ.0b013e3181d9bb3b_bb0095","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s10549-006-9444-0","article-title":"Paraneoplastic neurological syndromes and breast cancer. Regression of paraneoplastic neurological sensorimotor neuropathy in a patient with metastatic breast cancer treated with capecitabine: a case study and mini-review of the literature","volume":"105","author":"Minisini","year":"2007","journal-title":"Breast Cancer Res Treat"},{"key":"10.1097\/MAJ.0b013e3181d9bb3b_bb0100","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1212\/WNL.46.6.1739","article-title":"Pitfalls in the diagnosis of autoantibodies associated with paraneoplastic neurologic disease","volume":"46","author":"Sillevis-Smitt","year":"1996","journal-title":"Neurology"},{"key":"10.1097\/MAJ.0b013e3181d9bb3b_bb0105","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1212\/01.WNL.0000144340.03364.BF","article-title":"Value of Hu antibody determinations in the follow-up of paraneoplastic neurologic syndromes","volume":"63","author":"Llado","year":"2004","journal-title":"Neurology"},{"key":"10.1097\/MAJ.0b013e3181d9bb3b_bb0110","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1055\/s-2008-1040868","article-title":"Neuropathies associated with malignancy","volume":"18","author":"Amato","year":"1998","journal-title":"Semin Neurol"},{"key":"10.1097\/MAJ.0b013e3181d9bb3b_bb0115","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1093\/brain\/88.3.427","article-title":"The incidence of carcinomatous neuromyopathy in patients with various types of carcinoma","volume":"88","author":"Croft","year":"1965","journal-title":"Brain"},{"key":"10.1097\/MAJ.0b013e3181d9bb3b_bb0120","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1212\/WNL.50.3.652","article-title":"Paraneoplastic and oncologic profiles of patients seropositive for type 1 antineuronal nuclear autoantibodies","volume":"50","author":"Lucchinetti","year":"1998","journal-title":"Neurology"},{"key":"10.1097\/MAJ.0b013e3181d9bb3b_bb0125","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1056\/NEJM199906103402303","article-title":"A serological marker of paraneoplastic limbic and brainstem encephalitis in patients with testicular cancer","volume":"340","author":"Voltz","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1097\/MAJ.0b013e3181d9bb3b_bb0130","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1212\/01.wnl.0000196488.87746.7b","article-title":"Graus F: Paraneoplastic encephalomyelitis associated with pancreatic tumor and anti-GAD antibodies","volume":"66","author":"Hern\u00e1ndez-Echebarr\u00eda","year":"2006","journal-title":"Neurology"},{"key":"10.1097\/MAJ.0b013e3181d9bb3b_bb0135","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1177\/082585970101700110","article-title":"Hepatocarcinoma with concomitant paraneoplastic encephalomyelitis","volume":"17","author":"Coeytaux","year":"2001","journal-title":"J Palliat Care"},{"key":"10.1097\/MAJ.0b013e3181d9bb3b_bb0140","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1093\/brain\/88.3.529","article-title":"Immunofluorescent detection of antibodies against neurones in sensory carcinomatous neuropathy","volume":"88","author":"Wilkinson","year":"1965","journal-title":"Brain"},{"key":"10.1097\/MAJ.0b013e3181d9bb3b_bb0145","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1002\/ana.410440620","article-title":"Utility of anti-Hu antibodies in the diagnosis of paraneoplastic sensory neuropathy","volume":"44","author":"Molinuevo","year":"1998","journal-title":"Ann Neurol"},{"key":"10.1097\/MAJ.0b013e3181d9bb3b_bb0150","first-page":"881","article-title":"The expression of the Hu (paraneoplastic encephalomyelitis\/sensory neuronopathy) antigen in human normal and tumor tissues","volume":"141","author":"Dalmau","year":"1992","journal-title":"Am J Pathol"},{"key":"10.1097\/MAJ.0b013e3181d9bb3b_bb0155","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1136\/jnnp.11.2.73","article-title":"Primary sensory neuropathy with muscular changes associated with carcinoma","volume":"11","author":"Denny-Brown","year":"1948","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1097\/MAJ.0b013e3181d9bb3b_bb0160","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1136\/jnnp.63.2.133","article-title":"Paraneoplastic encephalomyelitis: an update of the effects of the anti-Hu immune response on the nervous system and tumour","volume":"63","author":"Voltz","year":"1997","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1097\/MAJ.0b013e3181d9bb3b_bb0165","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/1531-8249(199902)45:2<255::AID-ANA18>3.0.CO;2-N","article-title":"Epilepsia partialis continua: a new manifestation of anti-Hu-associated paraneoplastic encephalomyelitis","volume":"45","author":"Shavit","year":"1999","journal-title":"Ann Neurol"},{"key":"10.1097\/MAJ.0b013e3181d9bb3b_bb0170","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1159\/000078547","article-title":"Paraneoplastic sensorimotor neuropathy and encephalopathy associated with anti-alpha-enolase antibody in a case of gastric adenocarcinoma","volume":"51","author":"Tojo","year":"2004","journal-title":"Eur Neurol"},{"key":"10.1097\/MAJ.0b013e3181d9bb3b_bb0175","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1002\/ana.410390516","article-title":"Antiamphiphysin antibodies with small-cell lung carcinoma and paraneoplastic encephalomyelitis","volume":"39","author":"Dropcho","year":"1996","journal-title":"Ann Neurol"},{"key":"10.1097\/MAJ.0b013e3181d9bb3b_bb0180","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/00005072-199804000-00002","article-title":"POP66, a paraneoplastic encephalomyelitis related antigen, is a marker of adult oligodendrocytes","volume":"57","author":"Honnorat","year":"1998","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1097\/MAJ.0b013e3181d9bb3b_bb0185","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/AOG.0b013e3181af6bb6","article-title":"Paraneoplastic anti-N-methyl-d-aspartate-receptor encephalitis from mature cystic teratoma","volume":"114","author":"Kort","year":"2009","journal-title":"Obstet Gynecol"},{"key":"10.1097\/MAJ.0b013e3181d9bb3b_bb0190","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/ana.21050","article-title":"Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma","volume":"61","author":"Dalmau","year":"2007","journal-title":"Ann Neurol"},{"key":"10.1097\/MAJ.0b013e3181d9bb3b_bb0195","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1136\/jnnp.2007.136473","article-title":"Neurological response to early removal of ovarian teratoma in anti-NMDAR encephalitis","volume":"79","author":"Seki","year":"2008","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1097\/MAJ.0b013e3181d9bb3b_bb0200","first-page":"252","article-title":"Anti-NMDA receptor antibody-mediated encephalitis\/encephalopathy","volume":"57","author":"Iizuka","year":"2009","journal-title":"Rinsho Byori"},{"key":"10.1097\/MAJ.0b013e3181d9bb3b_bb0205","doi-asserted-by":"crossref","first-page":"923","DOI":"10.5692\/clinicalneurol.48.923","article-title":"Anti-NMDAR encephalopathy: treatment","volume":"48","author":"Suzuki","year":"2008","journal-title":"Rinsho Shinkeigaku"},{"key":"10.1097\/MAJ.0b013e3181d9bb3b_bb0210","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1002\/cncr.2820690536","article-title":"Paraneoplastic encephalomyelitis: dramatic response to chemotherapy alone","volume":"69","author":"Batson","year":"1992","journal-title":"Cancer"},{"key":"10.1097\/MAJ.0b013e3181d9bb3b_bb0215","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1212\/WNL.53.8.1719","article-title":"Clinical outcome of patients with anti-Hu-associated encephalomyelitis after treatment of the tumor","volume":"53","author":"Keime-Guibert","year":"1999","journal-title":"Neurology"},{"key":"10.1097\/MAJ.0b013e3181d9bb3b_bb0220","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1212\/WNL.42.3.536","article-title":"Plasmapheresis and antineoplastic treatment in CNS paraneoplastic syndromes and antineuronal autoantibodies","volume":"42","author":"Graus","year":"1992","journal-title":"Neurology"},{"key":"10.1097\/MAJ.0b013e3181d9bb3b_bb0225","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/NRL.0b013e31813e34a5","article-title":"Limbic encephalitis and variants: Classification, diagnosis and treatment","volume":"13","author":"Tuzun","year":"2007","journal-title":"Neurologist"},{"key":"10.1097\/MAJ.0b013e3181d9bb3b_bb0230","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1136\/jnnp.2005.073379","article-title":"Unusual magnetic resonance imaging and cerebrospinal fluid findings in paraneoplastic cerebellar degeneration: a sequential study","volume":"77","author":"De Andres","year":"2006","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1097\/MAJ.0b013e3181d9bb3b_bb0235","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/j.1365-2990.1997.tb01323.x","article-title":"Sub-acute cerebellar degeneration with anti-Yo autoantibodies: immunohistochemical analysis of the immune reaction in the central nervous system","volume":"23","author":"Giometto","year":"1997","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.1097\/MAJ.0b013e3181d9bb3b_bb0240","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s004010050460","article-title":"Inflammatory infiltrates and complete absence of Purkinje cells in anti-Yo-associated paraneoplastic cerebellar degeneration","volume":"91","author":"Verschuuren","year":"1996","journal-title":"Acta Neuropathol (Berl)"},{"key":"10.1097\/MAJ.0b013e3181d9bb3b_bb0245","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1212\/WNL.55.5.713","article-title":"Long-term clinical outcome of paraneoplastic cerebellar degeneration and anti-Yo antibodies","volume":"55","author":"Rojas","year":"2000","journal-title":"Neurology"},{"key":"10.1097\/MAJ.0b013e3181d9bb3b_bb0250","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1212\/01.WNL.0000041495.87539.98","article-title":"Anti-Tr antibodies as markers of paraneoplastic cerebellar degeneration and Hodgkin\u2019s disease","volume":"60","author":"Bernal","year":"2003","journal-title":"Neurology"},{"key":"10.1097\/MAJ.0b013e3181d9bb3b_bb0255","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s11060-007-9479-z","article-title":"Successful treatment of paraneoplastic cerebellar degeneration with Rituximab","volume":"86","author":"Esposito","year":"2008","journal-title":"J Neurooncol"},{"key":"10.1097\/MAJ.0b013e3181d9bb3b_bb0260","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1002\/1097-0142(19851101)56:9<2318::AID-CNCR2820560930>3.0.CO;2-9","article-title":"Successful treatment of subacute cerebellar degeneration in ovarian carcinoma with plasmapheresis. A case report","volume":"56","author":"Cocconi","year":"1985","journal-title":"Cancer"},{"key":"10.1097\/MAJ.0b013e3181d9bb3b_bb0265","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1023\/A:1023931501503","article-title":"Response to intravenous immunoglobulin in anti-Yo associated paraneoplastic cerebellar degeneration: case report and review of the literature","volume":"63","author":"Widdess-Walsh","year":"2003","journal-title":"J Neurooncol"},{"key":"10.1097\/MAJ.0b013e3181d9bb3b_bb0270","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s11060-006-9198-x","article-title":"Neurologic improvement after high-dose intravenous immunoglobulin therapy in patients with paraneoplastic cerebellar degeneration associated with anti-Purkinje cell antibody","volume":"81","author":"Phuphanich","year":"2008","journal-title":"J Neurooncol"},{"key":"10.1097\/MAJ.0b013e3181d9bb3b_bb0275","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0022-510X(01)00564-0","article-title":"Opsoclonus in three dimensions: oculographic, neuropathologic and modelling correlates","volume":"189","author":"Wong","year":"2001","journal-title":"J Neurol Sci"},{"key":"10.1097\/MAJ.0b013e3181d9bb3b_bb0280","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00002826-199619010-00001","article-title":"The immunopharmacology of the opsoclonus-myoclonus syndrome","volume":"19","author":"Pranzatelli","year":"1996","journal-title":"Clin Neuropharmacol"},{"key":"10.1097\/MAJ.0b013e3181d9bb3b_bb0285","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/ana.10462","article-title":"Autoantigen diversity in the opsoclonus-myoclonus syndrome","volume":"53","author":"Bataller","year":"2003","journal-title":"Ann Neurol"},{"key":"10.1097\/MAJ.0b013e3181d9bb3b_bb0290","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/ana.410290303","article-title":"Anti-Ri: an antibody associated with paraneoplastic opsoclonus and breast cancer","volume":"29","author":"Luque","year":"1991","journal-title":"Ann Neurol"},{"key":"10.1097\/MAJ.0b013e3181d9bb3b_bb0295","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/S0022-3476(97)70272-5","article-title":"Serum autoantibodies in childhood opsoclonus-myoclonus syndrome: an analysis of antigenic targets in neural tissues","volume":"130","author":"Connolly","year":"1997","journal-title":"J Pediatr"},{"key":"10.1097\/MAJ.0b013e3181d9bb3b_bb0300","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1093\/brain\/124.2.437","article-title":"Clinical outcome in adult onset idiopathic or paraneoplastic opsoclonus-myoclonus","volume":"124","author":"Bataller","year":"2001","journal-title":"Brain"},{"key":"10.1097\/MAJ.0b013e3181d9bb3b_bb0305","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1081\/CNV-120030214","article-title":"ANNA-2: an antibody associated with paraneoplastic opsoclonus in a patient with large-cell carcinoma of the lung with neuroendocrine features-correlation of clinical improvement with tumor response","volume":"22","author":"Erlich","year":"2004","journal-title":"Cancer Invest"},{"key":"10.1097\/MAJ.0b013e3181d9bb3b_bb0310","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/brain\/awf006","article-title":"Paraneoplastic peripheral neuropathy associated with anti-hu antibodies. A clinical and electrophysiological study of 20 patients","volume":"125","author":"Camdessanche","year":"2002","journal-title":"Brain"},{"key":"10.1097\/MAJ.0b013e3181d9bb3b_bb0315","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/NRL.0b013e3181870aa2","article-title":"Paraneoplastic neurological syndromes: a review","volume":"15","author":"Thomas","year":"2009","journal-title":"Neurologist"},{"key":"10.1097\/MAJ.0b013e3181d9bb3b_bb0320","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1212\/WNL.48.Suppl_5.23S","article-title":"Serological profile of myasthenia gravis and distinction from the Lambert-Eaton myasthenic syndrome","volume":"48","author":"Lennon","year":"1997","journal-title":"Neurology"},{"key":"10.1097\/MAJ.0b013e3181d9bb3b_bb0325","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1196\/annals.1254.065","article-title":"Lambert-Eaton myasthenic syndrome, diagnosis and treatment","volume":"998","author":"Sanders","year":"2003","journal-title":"Ann NY Acad Sci"},{"key":"10.1097\/MAJ.0b013e3181d9bb3b_bb0330","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1212\/WNL.54.3.603","article-title":"A randomized trial of 3,4-diaminopyridine in Lambert-Eaton myasthenic syndrome","volume":"54","author":"Sanders","year":"2000","journal-title":"Neurology"},{"key":"10.1097\/MAJ.0b013e3181d9bb3b_bb0335","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1212\/WNL.40.10.1552","article-title":"Response of Lambert-Eaton myasthenic syndrome to treatment of associated small-cell lung carcinoma","volume":"40","author":"Chalk","year":"1990","journal-title":"Neurology"}],"container-title":["The American Journal of the Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962915314774?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962915314774?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T23:06:46Z","timestamp":1559084806000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002962915314774"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":66,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["S0002962915314774"],"URL":"https:\/\/doi.org\/10.1097\/maj.0b013e3181d9bb3b","relation":{},"ISSN":["0002-9629"],"issn-type":[{"value":"0002-9629","type":"print"}],"subject":[],"published":{"date-parts":[[2010,10]]}}}